Literature DB >> 14717989

Soluble thrombomodulin in patients with established atherosclerosis.

V E A Gerdes, J A Kremer Hovinga, H Ten Cate, D P M Brandjes, H R Büller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14717989     DOI： 10.1111/j.1538-7836.2004.0562f.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Thromboembolic complications in Fontan patients: population-based prevalence and exploration of the etiology.

Authors:  L Idorn; A S Jensen; K Juul; J I Reimers; P I Johansson; K E Sørensen; S R Ostrowski; L Søndergaard
Journal:  Pediatr Cardiol       Date:  2012-07-28       Impact factor: 1.655

2.  Modulation of endothelial cell thrombomodulin by PPAR ligands--variation according to environment.

Authors:  Simone Mangan; Paula Clancy; Jonathan Golledge
Journal:  Thromb Res       Date:  2007-09-14       Impact factor: 3.944

3.  Thrombomodulin, alarmin signaling, and copeptin: cross-talk between obesity and acute ischemic stroke initiation and severity in Egyptians.

Authors:  Walaa A Keshk; Doaa H Zineldeen; Yasser A El-Heneedy; Azza A Ghali
Journal:  Neurol Sci       Date:  2018-04-10       Impact factor: 3.307

4.  Endothelial dysfunction and carotid atherosclerosis in Malawian adults: A cross-sectional study.

Authors:  Joseph Kamtchum-Tatuene; Gloria Mwangalika Kachingwe; Henry C Mwandumba; Tom Solomon; Laura A Benjamin
Journal:  eNeurologicalSci       Date:  2020-06-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.